SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-015045
Filing Date
2023-02-28
Accepted
2023-02-28 09:05:12
Documents
12
Period of Report
2023-02-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174379-8k_hoththera.htm   iXBRL 8-K 24184
  Complete submission text file 0001213900-23-015045.txt   199417

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hoth-20230224.xsd EX-101.SCH 3251
3 XBRL LABEL FILE hoth-20230224_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hoth-20230224_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT ea174379-8k_hoththera_htm.xml XML 3712
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 23678836
SIC: 2834 Pharmaceutical Preparations